Patients using antihistamines show decreased structural progression in knee osteoarthritis
Patients with knee osteoarthritis receiving antihistamines demonstrate less structural disease progression, compared with those who did not take antihistamines, over 2 years, according to data presented at the EULAR 2022 Congress.